Theriva Biologics (formerly VCN Biosciences)

📍 Sant Cugat del Vallès, Spain🗓 Founded 2022👥 8 employees💰 Last funded 2012
Theriva is a clinical-stage immuno-oncology company developing oncolytic viruses intended to overcome the protective barrier surrounding solid tumors and selectively kill tumor cells. Our developmental therapies are designed to enable systemic delivery and have the potential to enhance current standard-of-care therapies, offering patients with difficult-to-treat cancers the chance of a longer life. Theriva’s oncolytic viruses are engineered to enable systemic administration and selective tumor destruction, offering a powerful approach to treating a range of therapeutically challenging cancers. Our unique therapeutic properties overcome the limitations of traditional oncolytic viruses. Theriva’s oncolytic viruses have the potential to treat a broad range of difficult-to-treat tumor types and may be combined with a variety of cancer therapies. Our lead candidate VCN-01 continue sto demonstrate encouraging clinical evidence as we explore other technologies to expand our therapeutic approach.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2022
Founded
Investor geography1 country
Spain
1
Frequently asked questions
Who invested in Theriva Biologics (formerly VCN Biosciences)?
Theriva Biologics (formerly VCN Biosciences) has 1 investor on record on gritt.io, including 1 early-stage backers.
When did Theriva Biologics (formerly VCN Biosciences) last raise funding?
The most recent investment in Theriva Biologics (formerly VCN Biosciences) recorded on gritt.io was in 2012.
When was Theriva Biologics (formerly VCN Biosciences) founded?
Theriva Biologics (formerly VCN Biosciences) was founded in 2022.
What industry is Theriva Biologics (formerly VCN Biosciences) in?
Theriva Biologics (formerly VCN Biosciences) operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Theriva Biologics (formerly VCN Biosciences) based?
Theriva Biologics (formerly VCN Biosciences) is headquartered in Sant Cugat del Vallès, Spain.